A Two-Stage Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics and Immunogenicity of Various Doses of Levilimab When Administered Intravenously and Subcutaneously to Healthy Subjects and Subjects With Active Rheumatoid Arthritis
Clinical trial NCT05800327 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05800327
- Sponsor
- Biocad
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-07
- Primary completion
- 2024-09-01
- Enrollment
- 261
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.